Concepedia

Miki Takemura

MT

15

Publications

816

Citations

12

H-Index

2017

Active since

Affiliations

Shionogi (Japan)(Current)

Futaba (Japan)

Infectious Disease Consultants

Hartford Hospital

Shionogi (United States)

Miki Takemura is an author at Shionogi (Japan) specializing in clinical microbiology, drug resistance, and antibiotics.

ORCID

Top concepts

Publications per year

2017–2023

15

Publications

15

<i>In Vitro</i> Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

Akinobu Ito, Takafumi Sato, Merime Ota et al. · Antimicrobial Agents and Chemotherapy · 2017 · 356 citations · Full text

<i>In Vivo</i> Pharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection Models

Rio Nakamura, Tsukasa Ito-Horiyama, Miki Takemura et al. · Antimicrobial Agents and Chemotherapy · 2019 · 107 citations · Full text

Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials

Patrice Nordmann, Ryan K. Shields, Yohei Doi et al. · Microbial Drug Resistance · 2022 · 66 citations · Full text

Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing

Erika Matuschek, Christopher Longshaw, Miki Takemura et al. · Journal of Antimicrobial Chemotherapy · 2022 · 66 citations · Full text

Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan

Yoshinori Yamano, Naoki Ishibashi, Miho Kuroiwa et al. · Journal of Global Antimicrobial Resistance · 2021 · 36 citations · Full text

Rows per page

1–5 of 15